Vadodara

Astral SteriTech Pvt. Ltd (formaly known as Astral Pharmaceutical Industries), symbolises dedication to quality, sincerity towards work and passion to achieve 100% customer satisfaction. ASTRAL SteriTech has carved its Niche as the specialized contract manufacturing company in the area of its core competence - Sterile Antibiotic Powder Injectable formulations. ASTRAL SteriTech is poised to explore the opportunities offered by the Global market for sterile antibiotic powder injectable formulations on the strength of its unique manufacturing facilities, Quality systems and trained human resource.

Post : Assistant Quality Assurance Manager

Inspired and moved to share  below the essence of a true story which has unfolded in our own country in the recent past and in our own midst:

1. Which of the following trademarked sustained release systems are based on encapsulated drug particles that will dissolve at various rates ?  
I.   Sequels
II.   Spansules
III.  Extentabs.
Of these
A)  I only
B)  III Only
C) I and II
D) I, II, and III

Candidates after submitting their applications through On-Line shall send photocopies of their all academic/required documents regarding their claims along with print out of On-Line application form within 21 days from the last date of submitting the applications (date 03rd October, 2016 till 5.00 O' Clock) on the working day through registered/Speed Post or Personally in the office of the Commission.

Zydus Hospira Oncology Private Limited (ZHOPL) is a 50%-50% joint venture (JV) company between Zydus Cadila. India and Hospira (a Pfizer company), manufacturing cytotoxic injectable products (Finished Products). With our past success in more than 30 regulatory inspections including USFDA. MHRA, PMDA. Japan etc... we now embark upon a journey of Self Reliant and making ZHOPL, a Centre of Excellence (CoE) for Oncology products.

In 2014, a Core Committee was constituted under the Chairmanship of Dr. VM Katoch by the Indian Health Ministry to revise National List of Essential Medicines (NLEM), 2011. In the process of revision of NLEM, several consultations were held across the country with experts from different domains.

With global revenues of over US$ 4.5 billion, Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. We provide high-quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide. Sun Pharma is also India’s largest and most trusted pharmaceutical company. Our global presence is supported by 45 manufacturing facilities across 5 continents.

Post : Sr.Officer/Executive/Sr.Executive